logo
This Financial Services Stock Is My Fintech Exposure Pick

This Financial Services Stock Is My Fintech Exposure Pick

Yahoo29-07-2025
Written by Amy Legate-Wolfe at The Motley Fool Canada
When people think of fintech stocks, their minds often go to flashy U.S. names like Square, PayPal, or Robinhood. But right here in Canada, there's one under-the-radar name that offers exposure to the growing intersection of finance and technology: Bitfarms (TSX:BITF). While it might not fit the traditional mould of a bank-turned-tech firm, Bitfarms is building out a digital infrastructure that could make it a powerhouse in the financial services industry of the future.
An alternative fintech stock
Let's be clear: Bitfarms is not a bank, nor does it operate like one. It's a Bitcoin mining company. But with crypto adoption on the rise and institutions increasingly warming to digital assets, Bitfarms offers exposure to one of the fastest-evolving areas of fintech. It combines data centre operations, blockchain validation, and financial technology in a way that most traditional financial stocks simply don't.
And it's growing. In its first-quarter 2025 results, Bitfarms reported revenue of $67 million, up from 33% from the year before. That's driven by both higher production and increased transaction fees on the Bitcoin network. Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) came in at $16 million, down from $23 million in the same quarter of 2024. It also mined over 693 Bitcoin in Q2, up from the last quarter, but down from 2024 levels. With a new site opening in Paraguay and further upgrades across its Canadian facilities, Bitfarms is pushing for more scale and lower costs.
More to come
Of course, there are risks. This is a volatile fintech stock that moves closely with the price of Bitcoin. When Bitcoin fell sharply in 2022 and 2023, Bitfarms shares tumbled as well. But the company used that downturn to clean up its balance sheet, restructure its debt, and streamline operations. It ended the first quarter of 2025 with the flexibility to weather short-term crypto price swings.
More importantly, Bitfarms now has over 19.5 exahash per second of installed hashrate capacity, more than triple what it was a year ago. That makes it one of the largest and most efficient public miners in the world. As Bitcoin adoption continues and more financial services integrate crypto infrastructure, Bitfarms stands to benefit. It doesn't just mine coins, it validates transactions on a secure, decentralized network that underpins a new form of digital finance.
Considerations
So why consider this a fintech play? Because the future of finance is digital. From tokenized assets to blockchain-based lending, everything about the way we exchange value is evolving. Bitfarms doesn't build the apps; we're not talking about flashy consumer tech here, but it provides the back-end rails for a decentralized, digital financial future. That's the kind of exposure many fintech exchange-traded funds (ETF) completely miss.
Valuation-wise, Bitfarms is still inexpensive, especially considering its growth rate. The fintech stock's market cap is just over $964 million, and it trades at a fraction of the multiples you'd see with legacy fintech names. As the market begins to recognize digital infrastructure as a core part of the financial system, Bitfarms could re-rate much higher.
Bottom line
This isn't a pick for the faint of heart. The stock is volatile and tied closely to Bitcoin sentiment. But if you're looking for fintech exposure with higher risk and potentially higher reward, it's worth a look. Unlike some tech darlings that are all promise and no profit, Bitfarms is producing results. It's mining real assets, generating real cash, and scaling up operations with every quarter.
When everyone's looking at payment apps and digital wallets at the front end, it's easy to miss the infrastructure behind it all. Bitfarms gives investors exposure to that infrastructure. And if you believe that crypto will play a growing role in global finance, this Canadian miner could be your ticket into the backend of fintech. That's why it's my fintech exposure pick, even if it doesn't come wrapped in the usual tech packaging.
The post This Financial Services Stock Is My Fintech Exposure Pick appeared first on The Motley Fool Canada.
Should you invest $1,000 in Robinhood Markets, Inc. right now?
Before you buy stock in Robinhood Markets, Inc., consider this:
The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Robinhood Markets, Inc. wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.
Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $24,927.94!*
Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 30 percentage points since 2013*.
See the Top Stocks * Returns as of 6/23/25
More reading
10 Stocks Every Canadian Should Own in 2025
3 Canadian Companies Powering the AI Revolution
A Commonsense Cash Back Credit Card We Love
Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool recommends Block and PayPal. The Motley Fool has a disclosure policy.
2025
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Microsoft Sued For Killing Windows 10—All Users Must Act Now
Microsoft Sued For Killing Windows 10—All Users Must Act Now

Forbes

time2 minutes ago

  • Forbes

Microsoft Sued For Killing Windows 10—All Users Must Act Now

Microsoft knows 'many millions of users will not buy new devices or pay for extended support' when Windows 10 goes end of life in October, a new lawsuit alleges. 'These users,' it claims, 'will be at a heightened risk of a cyberattack or other data security incident, a reality of which Microsoft is well aware.' The lawsuit filed in California by Lawrence Klein, the owner of two Windows 10 laptops set to become obsolete in 8 weeks, 'seeks injunctive relief requiring Microsoft to continue providing support for Windows 10 without additional fees or conditions until the number of devices running the operating system falls below a reasonable threshold.' Around 45% of all Windows users are still on the soon to be obsolete version of the OS and must now act to ensure PCs are safe from attack. That number was dropping, albeit it has seen a reverse following Microsoft's decision to offer varying support extensions. That means 700 million users will be affected come October 14. Klein says Microsoft decided to kill the older OS when 'Windows 10 users represented more than half of the Windows operating system (OS) market share.' He also references the 240 million PCs that cannot upgrade, 'forcing' users to 'buy new devices capable of running Windows 11 or pay unanticipated sums for extended support.' Putting upgrade costs aside, the security risks are clear. Microsoft's 'long-term business strategy' Klein says, 'will have the effect of jeopardizing data security not only of Microsoft's customers but also of persons who may not use Microsoft's products at all.' Windows 10 users can now extend support by paying between $30 and $60 or by for free subject to certain parameters. That support extension is available to all Windows 10 users, whether or not their PCs meet the hardware requirements for Windows 11. Arguably, a better solution would be to extend Windows 10 support for free for PCs that can't upgrade, while mandating the upgrade for those that can. This lawsuit is the latest twist in a the windy road Windows 10 users have followed for the last year. Klein claims Microsoft's primary intent in killing Windows 10 is ' to force its customers to purchase new devices optimized to run Microsoft's suite of generative AI software such as Copilot, which comes bundled with Windows 11 by default.' This approach, Klein's lawsuit says, has the 'inevitable effect of decreasing trade in generative AI products of Microsoft's competitors, increasing the barriers to entry in the generative AI market, and dampening innovation and consumer choice.' Klein wants Windows 10 to be supported until less than 10% of the Windows user base is using that version of the OS. That means more than 600 million more PCs upgrading to Windows 11. That will take some considerable time. I have approached Microsoft for any response to the lawsuit.

Why Nektar Therapeutics Stock Popped 6% on Friday
Why Nektar Therapeutics Stock Popped 6% on Friday

Yahoo

timean hour ago

  • Yahoo

Why Nektar Therapeutics Stock Popped 6% on Friday

Key Points Investors were reacting to the biotech's second-quarter earnings report. Revenue was higher than analysts expected, although the net loss was deeper than the consensus. 10 stocks we like better than Nektar Therapeutics › Biotech Nektar Therapeutics (NASDAQ: NKTR) unveiled its latest quarterly earnings after the stock market's close on Thursday, and the investor reaction was strong the following day. Happily for Nektar, it was largely positive, and the share price increased by 6% today. This was well higher than the 0.8% gain posted by the S&P 500 index. Sweet results In its second quarter, Nektar booked total revenue of just under $11.2 million, which was less than half of the nearly $23.5 million in the same period of 2024. All of this derived from noncash royalty revenue connected to the sales of future royalties. This isn't unusual for a biotech without a commercialized product that depends on royalties and other payouts from partners. Nektar added that its cash and investments in marketable securities stood at just under $176 million at the end of the quarter (June 30). That, plus the roughly $107.5 million it should reap from a recent secondary share issue, should fund its operations into the first quarter of 2027. Meanwhile, the company's net loss for the second quarter was slightly over $39 million, or $2.78 per share. On average, analysts were projecting Nektar would book $9.7 million in revenue and a net loss of only $0.20 per share. I should note here that it can be challenging for even the most experienced professionals to estimate the results of biotechs that don't draw meaningful revenue from commercialized products. On a fast track All that said, there are several potential tailwinds for Nektar just now, and the company wasn't shy about itemizing them in its earnings release. Among the more promising is the U.S. Food and Drug Administration granting its Fast Track designation for rezpegaldesleukin, Nektar's investigational drug targeting severe-to-very-severe alopecia areata (a skin disorder). Do the experts think Nektar Therapeutics is a buy right now? The Motley Fool's expert analyst team, drawing on years of investing experience and deep analysis of thousands of stocks, leverages our proprietary Moneyball AI investing database to uncover top opportunities. They've just revealed their to buy now — did Nektar Therapeutics make the list? When our Stock Advisor analyst team has a stock recommendation, it can pay to listen. After all, Stock Advisor's total average return is up 1,047% vs. just 181% for the S&P — that is beating the market by 865.68%!* Imagine if you were a Stock Advisor member when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $636,563!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,108,033!* The 10 stocks that made the cut could produce monster returns in the coming years. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025 Eric Volkman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Why Nektar Therapeutics Stock Popped 6% on Friday was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Wells Fargo Lowers Honeywell (HON) Target, Cites Near-Term Market Uncertainty
Wells Fargo Lowers Honeywell (HON) Target, Cites Near-Term Market Uncertainty

Yahoo

timean hour ago

  • Yahoo

Wells Fargo Lowers Honeywell (HON) Target, Cites Near-Term Market Uncertainty

Honeywell International Inc. (NASDAQ:HON) is one of the best battery tech stocks to buy right now. Wells Fargo has kept a Hold rating on Honeywell International Inc. (NASDAQ:HON). On August 1, the analyst Joseph O'Dea lowered the price target from $240 to $230. Wells Fargo remains cautious about the company's near-term prospects. Pixabay/Public Domain Honeywell International Inc. (NASDAQ:HON) is a large company that works in many areas, including aerospace, building technologies, and energy solutions. The company has been making progress in battery-related projects this year. For example, Honeywell was chosen to provide automation systems for LG Energy Solution's new electric vehicle battery factory in Arizona. This shows Honeywell is involved in the growing market for batteries, which are important for electric cars and clean energy. Even with this progress, Wells Fargo remains careful because the overall market conditions are uncertain. There may be challenges that affect Honeywell's sales and profits in the short term. Investors might want to wait and see how the company performs before making decisions. The lower price target suggests that gains from the stock could be limited for now, but Honeywell's broad business areas could help it do well in the future. While we acknowledge the potential of HON as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the . READ NEXT: 12 Best Performing AI Stocks So Far in 2025 and 10 Best Military Tech Stocks to Buy Now Disclosure: None. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store